U.S. Oncology Research

U.S. Oncology Research is the clinical research arm of The US Oncology Network, one of the largest organizations of community-based oncology practices in the United States. The company specializes in conducting Phase 1 through Phase 4 clinical trials, providing patients with access to cutting-edge investigational therapies in a local, community setting. By partnering with leading pharmaceutical and biotechnology companies, U.S. Oncology Research has contributed to the development of over 100 FDA-approved cancer therapies. Their comprehensive services include trial design, site selection, regulatory management, and data collection across a vast network of affiliated physicians. The organization is a key player in advancing precision medicine and value-based care in the oncology space.